FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is a method of treatment of ischemic stroke (AI), including thrombolytic therapy, characterized in that the drug is prescribed Fortelisin® in a dose of 10 mg, which is administered with a single bolus for 10 seconds, regardless of body weight, no later than 4.5 hours from the onset of the disease in patients 18 years of age and older.
EFFECT: invention provides for the acceleration and simplification of the administration of the preparation, which makes it possible to expand the possibility of using the method in a therapeutic window limited to 4½ hours; reduction in the fall of fibrinogen; decrease the mortality of AI and increase the percentage of good functional recovery of patients.
1 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ACUTE MYOCARDIAL INFARCTION WITH STAGING OF ST SEGMENT COMPLICATED BY CARDIOGENIC SHOCK | 2017 |
|
RU2649760C1 |
| METHOD OF THROMBOLYTIC THERAPY IN STROKE | 2023 |
|
RU2820542C1 |
| METHOD OF TREATING PATIENTS WITH ST SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION | 2012 |
|
RU2483750C1 |
| METHOD OF DETERMINING INDICATIONS FOR CARRYING OUT INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE PERIOD OF ISCHEMIC STROKE | 2010 |
|
RU2444990C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ACUTE ISCHEMIC STROKE DURING 24 HOURS OF PERFORMING THROMBOLYTIC THERAPY | 2015 |
|
RU2573801C1 |
| METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
| METHOD FOR PREDICTING THE RECOVERY OF MOTOR FUNCTIONS IN PATIENTS IN THE ACUTE PERIOD OF ISCHEMIC STROKE | 2022 |
|
RU2792738C1 |
| METHOD FOR MONITORING PATIENTS WITH ACUTE CEREBROVASCULAR ACCIDENT | 2023 |
|
RU2820541C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING FIBRINOLYTIC EFFECT | 2007 |
|
RU2323001C1 |
| METHOD FOR DIAGNOSING SEVERITY OF ISCHEMIC STROKE | 2019 |
|
RU2712105C1 |
